Stephen Goldner is an accomplished inventor based in West Bloomfield, MI (US). He has made significant contributions to the field of cannabinoid research and product development. With a total of 3 patents to his name, Goldner's work focuses on innovative compositions and processes that enhance the efficacy of cannabinoids.

Latest Patents

Goldner's latest patents include a groundbreaking composition titled "Tablet or composition having n-acyl ethanolamine and cannabinoid." This composition features n-acyl ethanolamine, at least one cannabinoid, and at least one terpene, and is designed in the form of a tablet. Another notable patent is the "Freeze dry process," which involves a method for rupturing plant cells of cannabis through freeze-drying at temperatures below 0°C. This process aims to expose or release various chemicals, including cannabinoids, from the plant cells. Following the rupture, the method includes extracting these chemicals by pressurizing the cannabis with a solvent, which dissolves the cannabinoids. The subsequent depressurization precipitates the cannabinoids out of the solvent, allowing for their isolation.

Career Highlights

Throughout his career, Goldner has worked with various companies, including Pure Green Pharmaceuticals, Inc. His innovative approaches have contributed to advancements in cannabinoid applications and formulations.

Collaborations

Goldner has collaborated with notable professionals in the field, including Debra Kimless and John S Althaus. Their combined expertise has furthered the development of cannabinoid-related innovations.

Conclusion

Stephen Goldner's contributions to cannabinoid research and product development highlight his role as a significant inventor in the industry. His innovative patents and collaborations reflect a commitment to advancing the understanding and application of cannabinoids.

This text is generated by artificial intelligence and may not be accurate.